HPV18-E7 stabilizes HSPA5 to preserve GPX4-dependent redox defense in cervical cancer
Cellular Signalling · 2026
DOI: 10.1016/j.cellsig.2026.112840 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2026. Verfasst von Haibin Ou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital, Wuhan University, Wuhan 430071, China. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Phospholipid Hydroperoxide Glutathione Peroxidase, Heat-Shock Proteins, Human papillomavirus 18. Die Arbeit nennt 46 Literaturangaben. Gefördert von: Natural Science Foundation of Hubei Province.
Abstract (Originalsprache)
Cervical cancer remains a major cause of cancer-related morbidity and mortality in women worldwide. Although HPV18-positive tumors are frequently associated with aggressive clinicopathological behavior, the redox-linked mechanisms by which HPV18 drives cervical cancer progression remain incompletely defined. Here, integrated clinical, multi-omics, biochemical, and in vivo analyses were performed to delineate the role of HPV18-E7 in ferroptosis regulation. In the TCGA-CESC cohort, HPV18 positivity was associated with inferior progression-free survival and disease-free survival and was enriched in adenocarcinoma-related histology. Functionally, HPV18-E7 promoted cervical cancer cell proliferation and suppressed RSL3-induced ferroptotic death, lipid peroxidation, ferrous iron accumulation, and clonogenic loss. Integrated transcriptomic, proteomic, and metabolomic profiling identified ferroptosis defense, oxidative phosphorylation, glutathione/redox homeostasis, sulfur amino acid metabolism, and lipid remodeling as convergent pathways downstream of HPV18-E7. A lipid-focused re-analysis identified 41 features that met VIP > 1 and P < 0.05 in both knockdown comparisons and changed concordantly, of which 20 also met q < 0.05 in both comparisons. Reciprocal co-immunoprecipitation confirmed associations of HPV18-E7 with HSPA5 and of HSPA5 with GPX4. HPV18-E7 stabilized HSPA5 protein by attenuating K48-linked ubiquitination and proteasomal turnover, and thereby maintained GPX4 abundance. MG132, but not chloroquine under the tested condition, attenuated the loss of the HSPA5/GPX4 module after HPV18-E7 depletion, supporting a predominant proteasomal contribution in this setting. Gain- and loss-of-function rescue experiments established HSPA5 as a required downstream effector of HPV18-E7-mediated GPX4 maintenance and ferroptosis resistance. In a HeLa xenograft model, HPV18-E7 depletion markedly enhanced the antitumor efficacy of the ferroptosis inducer RSL3, accompanied by increased MDA and 4-HNE signals and reduced Ki67 and SCD1 expression. Collectively, these findings identify an HPV18-E7/HSPA5/GPX4 axis that promotes cervical cancer progression by preserving ferroptosis resistance, while lipid remodeling provides a complementary metabolic component of the phenotype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital, Wuhan University, Wuhan 430071, China.
- Breast cancer center, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430079, China. Electronic address: ptwkcw@126.com.
- Department of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430079, China; Breast cancer center, Hubei Cancer Hospital, Tongji Medical College, H…
Förderung
- Natural Science Foundation of Hubei Province
Zitieren
APA
Ou, H., Chen, W., & Xiong, Y. (2026). HPV18-E7 stabilizes HSPA5 to preserve GPX4-dependent redox defense in cervical cancer. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2026.112840
Vancouver
Ou H, Chen W, Xiong Y. HPV18-E7 stabilizes HSPA5 to preserve GPX4-dependent redox defense in cervical cancer. Cellular Signalling. 2026. doi:10.1016/j.cellsig.2026.112840
BibTeX
@article{Ou2026,
author = {Ou, Haibin and Chen, Wei and Xiong, Yudi},
title = {HPV18-E7 stabilizes HSPA5 to preserve GPX4-dependent redox defense in cervical cancer},
journal = {Cellular Signalling},
year = {2026},
doi = {10.1016/j.cellsig.2026.112840}
}
EUVIMED